Familial canine dermatomyositis is a hereditary,
idiopathic inflammatory condition of the skin and musclesof
young collies, Shetland sheepdogs, and their crosses. It has also
been reported in the Welsh corgi, ChowChow,
German shepherd dog, and Kuvasz and recognized in other purebred dogs.
The familial basis in other
breeds is unproved.
CAUSE AND PATHOGENESIS
The cause of dermatomyositis in humans or dogs is unknown. An immune-mediated pathogenesis issuspected because of detectable immunologic abnormalities, but it is unclear whether this immunologicreaction causes all of the changes seen or is in response to some pre-existing muscle or skin damage.Although dermatomyositis could be induced by drugs, infections (especially viral ones), toxins, or internalmalignancies, their causal relationship in dermatomyositis remains unproved.
A familial history is rare in humans, but common in collies and Shetland sheepdogs. Breeding studies incollies support an autosomal dominant mode of inheritance with variable expressivity. Limited studies in theShetland sheepdog conducted by one author (WHM) suggest a similar mode of inheritance in this breed.
CLINICAL FEATURES
In collies and Shetland sheepdogs, there is no sex, coat colour, or coat length association withdermatomyositis. This may or may not be true for other breeds. Because of the familial predisposition,lesions occur early in life, typically before 6 months of age. Signs in some dogs appear as early as 7 to 11weeks of age. The progression of lesions is variable. Some mildly affected dogs have few lesions, which healrapidly without scarring. Most dogs have new lesions after the first ones are recognized, but the rate ofprogression is variable. The extent of the skin lesions is known by one year of age. Unless managementchanges occur, lesions usually decrease in number and severity from that point on.
Skin lesions occur in areas of mechanical
trauma and are commonly seen on the face (see Fig. 11:22C and D),especially
around the eyes (Fig. 11:22E); on the tips of the ears; on caral and tarsal
regions (Fig. 11:22F); onthe digits;
and on the tip of the tail (Fig. 11:22G). Oral and footpad lesions
can be seen but are rare.
Although intack vesicles can be seen in some
dogs, primary lesions are usually absent. Typical skin lesionsare
characterized by alopecia, erythema, scaling, and mild crusting.
Ulceration can be seen in severelyaffected
dogs, large areas of normal skin remain, whereas severely affected dogs
have involvement of theentire face, distal
limbs, and tail. Some dogs have long, soft claws.
The myositits typically occurs after the skin
lesions are recognized and correlated with the severity of theskin
lesions. Mildly affected dogs have no clinical muscle disease and
convincing evidence of this may not befound
on EMG testing or muscle biopsy. These cases may have epidermolyisis
bullosa, dermatomyositis with
focal but undetected myotitis, or dermatomyositis
without the myositis. In humans, the diagnosis ofamyopathic
dermatomyositis can be made only when no muscle changes are detected for
4 years or longerafter the skin lesions
have occurred. To the authors’ knowledge, this type of follow-up
testing has not beendone in dogs.
The rare dog related to dogs with classic dermatomyositis has EMG changes
of myositis withno skin lesions.
The significance of these findings is unknown.
Clinical signs of myositis are variable.
A common finding is a dirty water bowl that contains food particles.
These dogs do not have trouble chewing their
food but do not swallow it completely; so residual pieces arewashed
from the mouth during drinking. Some dogs have a peculiar high-stepping
gait. Severely affecteddogs drink,
chew, and swallow with difficulty; have a stiff gait; have megaoesophagus;
and often havesecondary aspiration pneumonia.
The most common sign of the mypositis is asymptomatic atrophy,especially
of the muscles of mastication and distal limbs.
The rare dog has skin lesions only in adulthood. The lesions can be the classic superficial lesions ofdermatomyositis or be more deeply ulcerated (see Idiopathic Ulcerative Dermatomyositis in ShetlandSheepdogs and Collies in this chapter). These cases could represent an adult-onset variant of the diseases orbe dogs who had mild, unrecognized disease as puppies.
DIAGNOSIS
The differential diagnostic considerations should include demodicosis, staphylococcal folliculitis,dermatophytosis, discoid lupus erythematosus, and epidermolyisis bullosa. The latter might be considered ifthere are no muscle signs or lesions and if vesicles are present.
Diagnosis is made by history, physical examination
findings, biopsy of affected skin and muscle, EMG, andlaboratory
tests to rule out other conditions. Biopsy of affected skin shows
scattered vacuolar change of thesurface
and follicular basal cells (Fig. 11:23). Occasional apoptotic basal
cells (Civatt’s bodies) may be seen.
With confluent hydropic change, intrabasal
or subepidermal clefting may be seen (Fig. 11:24). Dermalinflammation
can be absent. Most cases show a mild perivascular to interstitial
dermatitis in whichlymphocytes, plasma
cells and histiocytes predominate. Mild pigmentary incontinence may
be present in thesuperficial dermis.
Follicular atrophy and fibrosis are common findings (Figs 11:25 and 11:26).
Vasculitismay occasionally be seen in
the skin. Muscle biopsy may show mixed inflammatory exudates, accompaniedby
muscle fiber necrosis and atrophy. In some cases, a vasculitis may
be found. Needle EMG abnormalitiesinclude
positive sharp waves and fibrillation potentials in muscles of the head
and of distal extremities.
Hemograms and serum chemistry profiles are
usually unremarkable. Creatine kinase levels are normal orslightly
increased. Neurologic examination and nerve conduction studies are
usually normal. Elevatedconcentrations
of immunoglobulin G and circulating immune complexes may be found in active
disease. The
magnitude of the elevations in immunoglobulin
G and circulating immune complex levels correlates with theseverity
of the skin disease.
CLINICAL MANAGEMENT
The skin lesions of dermatomyositis are worsened
by trauma and prolonged solar exposure. Management changes to avoid
these secondary insults should be instituted. Mildly affected dogs
usually require noadditional treatment,
as their skin lesions heal spontaneously. Severely affected
dogs are difficult to
manage. These dogs have widespread
skin lesions and a generalized myopathy, which results in lamenessand
difficulty in drinking and eating. These dogs often have aspiration
pneumonia. Although large doses ofPrednisolone
(1 mg/kg q24h) improves the skin lesions, the disease is progressive and
euthanasia should be
encouraged.
Mildly to moderately affected dogs can usually
be maintained as acceptable pets for extended periods. Someskin
lesions remain and muscle atrophy, especially of the muscles of mastication,
is noted. Oral does ofvitamin E
(200 to 800 IU/day) or marine lip supplements (e.g. DVM Derm Caps) appear
to be beneficial for
the skin but not the muscle lesions..
Occasional use of Prednisolone (1 mg/kg q24h) is necessary in somedogs
for traumatic flares. Continued use of glucocorticoids should be
discouraged because the muscle atrophymay
be aggravated.
Treatment with pentoxifylline (Trental
[Hoecsht-Roussel]) has been recommended. This drug increasestissue
oxygenation by increasing microvascular blood flow. It is a gastric
irritant and must be given withfood.
Dosages of 400 mg every 24 to 48 hours have been suggested. Response
is slow, and 2 to 3 months of
treatment are necessary before efficacy can
be determined. No data are available on the efficacy of thistreatment.
The above treatments usually minimize the
development of new skin lesions, and those that do occur tend tobe
milder. Muscle disease progresses and old dogs have profound atrophy
of the muscles of the head, thedistal
limbs, and sometimes the body. With severe atrophy, the animal’s
ability to eat and drink can be
compromised and dietary manipulations are
necessary. The limb and body atrophy can cause an abnormalgait,
but locomotion is till possible. Amyloidosis can occur in some chronically
affected dogs.